menu
    • menu

    Company profile for Ikena Oncology

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ikena, headquartered in the biotech hub of Boston, Massachusetts, is dedicated to bringing next generation oncology therapies to patients suffering from cancer. We are committed to leveraging our unique understanding of the complex biologic pathways that drive the formation and spread of cancers to discover and develop novel, patient-directed therapies. Selecting patients for treatment in clinical studies with biomarkers we de...
    Ikena, headquartered in the biotech hub of Boston, Massachusetts, is dedicated to bringing next generation oncology therapies to patients suffering from cancer. We are committed to leveraging our unique understanding of the complex biologic pathways that drive the formation and spread of cancers to discover and develop novel, patient-directed therapies. Selecting patients for treatment in clinical studies with biomarkers we develop is at the core of our strategy.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ikena OncologyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    50 Northern Avenue Boston, MA 02210
    Telephone
    Telephone
    (857) 273-8343
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://ikenaoncology.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ikenaoncology/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ikenaoncology

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Inmagene Biopharmaceuticals Completes Merger with Ikena Oncology
    Inmagene Biopharmaceuticals Completes Merger with Ikena Oncology

    25 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/25/3121877/0/en/Inmagene-Biopharmaceuticals-Announces-Completion-of-Merger-with-Ikena-Oncology-and-Concurrent-Private-Placement-of-75-Million.html

    GLOBENEWSWIRE
    25 Jul 2025
    Share Share
    Kristin Yarema Named CEO of Merged Ikena-Inmagene Entity
    Kristin Yarema Named CEO of Merged Ikena-Inmagene Entity

    23 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/23/3120280/0/en/Ikena-Oncology-and-Inmagene-Biopharmaceuticals-Announce-Kristin-Yarema-Ph-D-as-Chief-Executive-Officer-of-Merged-Company.html

    GLOBENEWSWIRE
    23 Jul 2025
    Share Share
    Ikena Announces Stockholder Approval of Merger with Inmagene Bio
    Ikena Announces Stockholder Approval of Merger with Inmagene Bio

    15 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/15/3116027/0/en/Ikena-Oncology-Announces-Stockholder-Approval-of-Merger-with-Inmagene-Biopharmaceuticals.html

    GLOBENEWSWIRE
    15 Jul 2025
    Share Share
    Ikena-Inmagene Merger Backed by ISS, Glass Lewis
    Ikena-Inmagene Merger Backed by ISS, Glass Lewis

    11 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/11/3113954/0/en/Ikena-Oncology-Announces-ISS-and-Glass-Lewis-Recommend-Stockholders-Vote-FOR-Proposed-Merger-with-Inmagene-Biopharmaceuticals.html

    GLOBENEWSWIRE
    11 Jul 2025
    Share Share
    Ikena Oncology and Inmagene Announce Merger, Placement
    Ikena Oncology and Inmagene Announce Merger, Placement

    23 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/23/3001242/0/en/Ikena-Oncology-and-Inmagene-Biopharmaceuticals-Announce-Agreement-for-Merger-and-Private-Placement.html

    GLOBENEWSWIRE
    23 Dec 2024
    Share Share
    Ikena Oncology Reports Q3 2024 Financial Results
    Ikena Oncology Reports Q3 2024 Financial Results

    07 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/07/2976692/0/en/Ikena-Oncology-Reports-Third-Quarter-2024-Financial-Results.html

    GLOBENEWSWIRE
    07 Nov 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search